Blueberry Therapeutics have unique nanopolymer drug delivery technology which opens up huge opportunities to rapidly develop new medicines and helps us find ways to treat infection & inflammation.

Infection

Blueberry is committed to the development of innovative therapies to treat diseases where infection and inflammation are major factors.

Inflammation

We use cutting-edge nano polymer drug delivery technology to exploit both small molecule and biologic approaches to developing treatments.

News

Blueberry in the news again!

Blueberry's CEO John Ridden was interviewed by Times writer Michael Cape. John and Michael spoke about how Blueberry benefitted [...]

March 16th, 2017|

0
Drugs in our pipeline
0
Patents and exclusives licences
0
Billion dollars in commercial potential